![](/img/cover-not-exists.png)
81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases
Gettinger, S.N., Bazhenova, L., Salgia, R., Langer, C.J., Gold, K.A., Rosell, R., Shaw, A.T., Weiss, G.J., Narasimhan, N.I., Dorer, D.J., Rivera, V.M., Clackson, T., Haluska, F.G., Camidge, D.R.Volume:
87
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(15)50080-9
Date:
January, 2015
File:
PDF, 48 KB
english, 2015